Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment

Open access
Teng, Y. K. Onno, Levarht, E. W. Nivine, Hashemi, Mojtaba, Bajema, Ingeborg M., Toes, René E. M., Huizinga, Tom W. J., van Laar, Jacob M.·2007·Arthritis & Rheumatism

Abstract

Objective: Anti‐CD20–mediated B cell depletion with rituximab is a new and effective therapy for rheumatoid arthritis (RA). Although B cells in peripheral blood (PB) are consistently depleted in all patients, the clinical effects are more heterogeneous, possibly related to differences in the depleting effects of lymphoid or solid tissues. The aim of this study was to investigate B cell depletion in different compartments (PB, bone marrow, and synovium) and determine predictive variables for responsiveness to rituximab therapy. Methods: Before and 12 weeks after rituximab treatment, samples of PB, bone marrow, and synovium were collected from 25 patients with RA refractory to disease‐modifying antirheumatic drugs and tumor necrosis factor–blocking agents. CD19+ and CD20+ B cells in PB and bone marrow were measured by flow cytometric analysis, whereas CD79a+ and cytoplasmic CD20+ B cells in the synovium were stained by immunohistochemistry. The effects of rituximab on serum Ig and autoantibodies were measured by enzyme‐linked immunosorbent assay. Results: Rituximab effectively depleted the CD20+ subset of B cells in the PB, bone marrow, and synovium of RA patients. Rituximab significantly reduced autoantibody production (anti–citrullinated protein antibodies [ACPAs] and rheumatoid factor [RF]), in part due to a nonspecific decrease in total Ig production. Importantly, positivity for circulating ACPA IgM, in combination with a high infiltration of CD79a+ B cells in the synovium, but not of CD138+ plasma cells, was a predictor of clinical outcome after rituximab treatment. ACPA IgM titers were independently associated with synovial infiltration of CD20−,CD79a+ B cells, but not with CD138+ plasma cells. Conclusion: These data provide novel insights into the mechanisms of CD20‐mediated B cell depletion in the lymphoid and solid tissues of RA patients and suggest a pivotal role for ACPA IgM–producing plasmablasts in RA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.22967

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 171

Metadata

Authors
Teng, Y. K. O., Levarht, E. W. N., Hashemi, M., Bajema, I. M., Toes, R. E. M., Huizinga, T. W. J., & van Laar, J. M.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2007-11-29
Volume
56
Issue
12
Pages
3909-3918
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W1993847760
Cited by
171
References
1
FWCI
13.03
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. https://app.cochat.ai/papers/10.1002/art.22967
The paper
Teng, Y. K. O., Levarht, E. W. N., Hashemi, M., Bajema, I. M., Toes, R. E. M., Huizinga, T. W. J., & van Laar, J. M. (2007). Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Arthritis & Rheumatism. https://doi.org/10.1002/art.22967

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.